Eagle Pharmaceuticals Inc
OTC:EGRX
Eagle Pharmaceuticals Inc
OTC:EGRX
Price:
0.95
USD
Market Closed
Market Cap:
$12.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Eagle Pharmaceuticals Inc
OTC:EGRX
|
US |
|
H
|
Haverty Furniture Companies Inc
F:25F
|
US |
|
I
|
Insulet Corp
SWB:GOV
|
US |
|
R
|
Reach PLC
F:MRR
|
UK |
|
N
|
Nimy Resources Ltd
ASX:NIM
|
AU |
|
URU Metals Ltd
F:NVRA
|
CA |
|
Scully Royalty Ltd
F:MB01
|
CN |
|
A
|
Arcos Dorados Holdings Inc
F:AD8
|
UY |
|
B
|
Buru Energy Ltd
F:BUD
|
AU |
|
V
|
Vilkyskiu Pienine AB
XMUN:UDW
|
LT |
|
Fideicomiso Irrevocable de Emision de Certificados Bursatiles Fiduciarios Inmobiliarios Administracion y Pago Numero CIB/572
BMV:STORAGE18
|
MX |
|
Rapid Critical Metals Ltd
F:35S
|
AU |
|
ESR-REIT
OTC:CGIUF
|
SG |
|
Ferguson Enterprises Inc
F:UH3
|
US |
|
N
|
NetApp Inc
DUS:NTA
|
US |
|
S
|
Swire Properties Ltd
OTC:SWPFF
|
HK |
|
H
|
H & R Block Inc
XMUN:HRB
|
US |
|
M
|
MTU Aero Engines AG
XMUN:MTX
|
DE |
|
T
|
T&R Biofab Co Ltd
KOSDAQ:246710
|
KR |
|
Siemens AG
F:SIEB
|
DE |
|
Utah Medical Products Inc
F:UTM
|
US |
|
Curro Holdings Ltd
F:24P
|
ZA |
|
V
|
Valeo SE
F:VSA
|
FR |
|
S
|
Sprott Inc
F:A781
|
CA |
Intrinsic Value
Not Available for EGRX
There is not enough data to reliably calculate the intrinsic value for Eagle Pharmaceuticals Inc.
Do our valuations actually work? See backtest results .
Alternatives to EGRX
Fundamental Analysis
What Eagle Pharmaceuticals Does
Eagle Pharmaceuticals, Inc. is a biotechnology pharmaceutical company, which focuses on developing and commercializing injectable products primarily in the metabolic critical care and oncology areas in the United States. The company is headquartered in Woodcliff Lake, New Jersey and currently employs 134 full-time employees. The company went IPO on 2014-02-12. The firm is focused on developing medicines that result in improvements in patients' lives.
- Headquarters
- United States of America US
- Employees
- 134
- IPO date
- Feb 12, 2014
Financials
Revenue & Expenses Breakdown
Eagle Pharmaceuticals Inc
Eagle Pharmaceuticals Inc
Efficiency
Earnings Waterfall
Eagle Pharmaceuticals Inc
Eagle Pharmaceuticals Inc
